Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone

Journal of Studies on Alcohol and Drugs

Volumn 74, Issue 6, 2013, Pages 894-901

  Vuoristo Myllys, Salla ^a,b   Lahti, Jari ^a,c   Alho, Hannu ^b,d   Julkunen, Juhani ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c FOLKHÄLSAN RESEARCH CENTER   (Finland)

^d BIOMEDICUM HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; NARCOTIC ANTAGONIST;

ADULT; AGED; ALCOHOLISM; AMBULATORY CARE; ANALYSIS OF VARIANCE; ARTICLE; COGNITIVE THERAPY; FEMALE; HUMAN; LENGTH OF STAY; MALE; MEDICATION COMPLIANCE; METHODOLOGY; MIDDLE AGED; MOTIVATION; OUTPATIENT; PATIENT DROPOUTS; PSYCHOLOGICAL ASPECT; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS; STATISTICS; YOUNG ADULT;

ADULT; AGED; ALCOHOLISM; AMBULATORY CARE; ANALYSIS OF VARIANCE; COGNITIVE THERAPY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; NALTREXONE; NARCOTIC ANTAGONISTS; OUTPATIENTS; PATIENT DROPOUTS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84888356169     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2013.74.894     Document Type: Article

References (41)

1. Adamson, S. J., Heather, N., Morton, V., & Raistrick, D., & the UKATT Research Team. (2010). Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol and Alcoholism, 45, 136-142.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.) Washington, DC: American Psychiatric Press.
3. Anton, R. F., Moak, D. H., & Latham, P. K. (1995). The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantifi cation of thoughts about alcohol and drinking behavior. Alcoholism: Clinical and Experimental Research, 19, 92-99.
4. Anton, R. F., Moak, D. H., & Latham, P. K. (1996). The Obsessive Compulsive Drinking Scale: A new method of assessing outcome in alcoholism treatment studies. Archives of General Psychiatry, 53, 225-231.
5. Anton, R. F., Moak, D. H., Latham, P. K., Waid, L. R., Myrick, H., Voronin, K.,. Woolson, R. (2005). Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. Journal of Clinical Psychopharmacology, 25, 349-357.
6. Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999). Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. American Journal of Psychiatry, 156, 1758-1764.
7. Baekeland, F., & Lundwall, L. (1975). Dropping out of treatment: A critical review. Psychological Bulletin, 82, 738-783.
8. Bien, T. H., Miller, W. R., & Tonigan, J. S. (1993). Brief interventions for alcohol problems: A review. Addiction, 88, 315-336.
9. DiClemente, C. C., Bellino, L. E., & Neavins, T. M. (1999). Motivation for change and alcoholism treatment. Alcohol Research & Health, 23, 86-92.
10. Elbreder, M. F., de Souza e Silva, R., Pillon, S. C., & Laranjeira, R. (2011). Alcohol dependence: Analysis of factors associated with retention of patients in outpatient treatment. Alcohol and Alcoholism, 46, 74-76.
11. Feinn, R., Tennen, H., Cramer, J. & Kranzler, H. R. (2003) Measurement and prediction of medication compliance in problem drinkers. Alcoholism: Clinical and Experimental Research, 27, 1286-1292.
12. Gottheil, E., McLellan, A. T., & Druley, K. A. (1992). Length of stay, patient severity and treatment outcome: Sample data from the fi eld of alcoholism. Journal of Studies on Alcohol, 53, 69-76.
13. Graham, J. W., Hofer, S. M., Donaldson, S. I., McKinnon, D. P., & Schafer, J. L. (1997). Analysis with missing data in prevention research. In K. Bryant, M. Windle, & S. West (Eds.), The science of prevention: Methodological advances from alcohol and substance abuse research (pp. 325-366). Washington DC: American Psychological Association.
14. Heinälä, P., Alho, H., Kiianmaa, K., Lönnqvist, J., Kuoppasalmi, K., & Sinclair, J. D. (2001). Targeted use of naltrexone without prior detoxifi-cation in the treatment of alcohol dependence: A factorial double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 21, 287-292.
15. Killeen, T. K., Brady, K. T., Gold, P. B., Simpson, K. N., Faldowski, R. A., Tyson, C., & Anton, R. F. (2004). Effectiveness of naltrexone in a community treatment program. Alcoholism: Clinical and Experimental Research, 28, 1710-1717.
16. King, A. C., & Canada, S. A. (2004). Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. Journal of Substance Abuse Treatment, 26, 189-195.
17. Klein, C., di Menza, S., Arfken, C., & Schuster, C. R. (2002). Interaction effects of treatment setting and client characteristics on retention and completion. Journal of Psychoactive Drugs, 34, 39-50.
18. Mammo, A., & Weinbaum, D. F. (1993). Some factors that infl uence dropping out from outpatient alcoholism treatment facilities. Journal of Studies on Alcohol, 54, 92-101.
19. Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. New York, NY: Guilford Press.
20. McCaul, M. E., Svikis, D. S., & Moore, R. D. (2001). Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence, 62, 9-17.
21. McKellar, J., Kelly, J., Harris, A., & Moos, R. (2006). Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addictive Behaviors, 31, 450-460.
22. Miller, W. R., & Tonigan, J. S. (1996). Assessing drinkers' motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychology of Addictive Behaviors, 10, 81-89.
23. Monterosso, J. R., Flannery, B. A., Pettinati, H. M., Oslin, D. W., Rukstalis, M., O'Brien, C. P., & Volpicelli, J. R. (2001). Predicting treatment response to naltrexone: The infl uence of craving and family history. The American Journal on Addictions, 10, 258-268.
24. Monti, P. M., Rohsenow, D. J., Swift, R. M., Gulliver, S. B., Colby, S. M., Mueller, T. I.,. Asher, M. K. (2001). Naltrexone and cue exposure with coping and communication skills training for alcoholics: Treatment process and 1-year outcomes. Alcoholism: Clinical and Experimental Research, 25, 1634-1647.
25. Moos, R. H., & Moos, B. S. (2003). Long-term infl uence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders. Addiction, 98, 325-338.
26. Pulford, J., Adams, P., & Sheridan, J. (2006). Unilateral treatment exit: A failure of retention or a failure of treatment fi t? Substance Use & Misuse, 41, 1901-1920.
27. Roberts, J. S., Anton, R. F., Latham, P. K., & Moak, D. H. (1999). Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcoholism: Clinical and Experimental Research, 23, 1484-1491.
28. Roche, A. M., Parle, M. D., Stubbs, J. M., Hall, W., & Saunders, J. B. (1995). Management and treatment efficacy of drug and alcohol problems: What do doctors believe? Addiction, 90, 1357-1366.
29. Rohsenow, D. J., Colby, S. M., Monti, P. M., Swift, R. M., Martin, R. A., Mueller, T. I.,. Eaton, C. A. (2000). Predictors of compliance with naltrexone among alcoholics. Alcoholism: Clinical and Experimental Research, 24, 1542-1549.
30. Rösner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M., & Soyka, M. (2010). Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews, Issue 9, Article No. CD004332.
31. Rubin, D. B. (1987). Multiple imputation for nonresponse surveys. New York, NY: Wiley.
32. Ryan, R. M., Plant, R. W., & O'Malley, S. (1995). Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout. Addictive Behaviors, 20, 279-297.
33. Sheehan, D. V., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A.,. Dunbar, G. C. (1997). The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry, 12, 232-241.
34. Sinclair, J. D. (2001). Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol and Alcoholism, 36, 2-10.
35. Sinclair, D., & Jakobson, B. (1996). ConrAl Clinics treatment manual. Unpublished manual.
36. Soyka, M., Hasemann, S., Scharfenberg, C. D., Löhnert, B., & Bottlender, M. (2003). Prospektive Untersuchung zur Effizienz der ambulanten Entwöhnungstherapie bei alkoholabhängigen Patienten [New possibilities in treatment and rehabilitation of alcohol-dependent patients-a catamnestic study on the efficiency of outpatient treatment programmes demonstrated by a model procedure]. Der Nervenarzt, 74, 226-234.
37. Swift, R., Oslin, D. W., Alexander, M., & Forman, R. (2011). Adherence monitoring in naltrexone pharmacotherapy trials: A systematic review. Journal of Studies on Alcohol and Drugs, 72, 1012-1018.
38. Veach, L. J., Remley, T. P., Jr., Kippers, S. M., & Sorg, J. D. (2000). Retention predictors related to intensive outpatient programs for substance use disorders. American Journal of Drug and Alcohol Abuse, 26, 417-428.
39. Welte, J., Hynes, G., Sokolow, L., & Lyons, J. P. (1981). Effect of length of stay in inpatient alcoholism treatment on outcome. Journal of Studies on Alcohol, 42, 483-491.
40. World Health Organization. (2000). International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva: WHO.
41. Wickizer, T., Maynard, C., Atherly, A., Frederick, M., Koepsell, T., Krupski, A., & Stark, K. (1994). Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. American Journal of Public Health, 84, 215-221.